Informations générales (source: ClinicalTrials.gov)
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE) (ELEGANCE)
Observational [Patient Registry]
Boston Scientific Corporation (Voir sur ClinicalTrials)
mars 2021
janvier 2028
17 octobre 2024
The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including
populations previously not represented in Peripheral Vascular Disease (PVD) trials,
health economics data, and to support the safe use of commercially available Boston
Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in
the peripheral vasculature.
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| GH PARIS SITE SAINT JOSEPH | Contact (sur clinicalTrials) | ||||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Hospital Marie Lannelongue - 92350 - Le Plessis-Robinson - France | Contact (sur clinicalTrials) | ||||
Critères
Tous
Inclusion Criteria:
- Patients 18 years and older
- Written informed consent (patient data release-form)
- Use of any commercially available Boston Scientific drug-eluting device marketed for
treatment of lesions in the peripheral vasculature and specified in the Registry
Enrollment Guide
- Patients 18 years and older
- Written informed consent (patient data release-form)
- Use of any commercially available Boston Scientific drug-eluting device marketed for
treatment of lesions in the peripheral vasculature and specified in the Registry
Enrollment Guide
- Life expectancy of <1 year